@tbtmd Hi Doc: Being a long with PTLA too I am also concerned about the Q4. It certainly showed some fragility to the rampup. However hospital drugs are difficult. Wish they had partnered EU and entirely focused on US. EU partnership may be easier if we get good feedback from NICE UK to start the pricing deals. I really hope the BOD/SG are not ignoring partnership requests unless they are too cheap offers. IMO they may not have received good deal yet
  • 1